Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
about
Medical methods for first trimester abortionMedical methods for first trimester abortionClinical applications of mifepristoneEfficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 daysA consensus regimen for early abortion with misoprostol.Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice.Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans.A Prospective Trial Using Mifepristone and Vaginal Misoprostol in Termination of Pregnancies up to 63 Days of Gestation.Is mifepristone 100mg an effective alternative to standard dose for medical abortion.A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.Home administration of misoprostol for early medical abortion in India.Low dose Mifepristone (100 mg) for medical termination of pregnancy.Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?The acceptability of home medical abortion to women in UK settings.Misoprostol alone for early medical abortion in a Latin American clinic setting.Reaching women with instructions on misoprostol use in a Latin American country.Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France.Emotional impact and acceptability of medical abortion with mifepristone: a German experience.Development of medical termination of pregnancy: a review.Misoprostol for uterine evacuation in induced abortion and pregnancy failure
P2860
Q24235336-8BFB5104-6746-411E-80B8-DC3D6948D63CQ24247370-5DA0D5B3-50A6-4260-8C22-6517F68DE5D1Q28278425-7D230C00-1491-41EE-B3AB-AC2B8F0ECC08Q35217614-B8B42483-EB2C-4F6F-ADCD-CEA6286728CEQ35952723-9B67934D-56AB-4818-AF70-3B5A725D4323Q35980618-439089FD-BE58-4E84-8CBE-80E938B5C4F0Q36901146-F7E21509-401F-4AC1-9504-3DBC210CB0E0Q37468184-BF0FB12B-92F0-47DA-BD22-883F304AE7F4Q37611187-256B1867-7148-4E75-B0A4-225E7C1DE5B6Q38959943-7E66E4A6-91E5-4171-99AD-87A93D95003FQ40274871-11DCCA55-AA4F-4538-BDE9-CAD94097AFD7Q43234266-EB5335B4-866A-4B86-B013-2389FAD8907EQ45895955-13954706-89B8-41AF-913E-0C467490159DQ46104100-E0B0E477-430A-42EB-AC7D-C40CA068CF05Q46203759-2688E62C-0C09-4305-96AA-0782DC6F3A7CQ46517558-AF1770CE-7B9E-480F-9D01-A01D5E4BA3D5Q46529914-003023B4-E244-44E0-AF89-FA8478066519Q46807441-E85CE35E-F57A-4041-802A-AA1C3B15076BQ46828541-ADDBF1F0-3B2F-4F86-AE1F-0E657C56AA63Q48484559-DCAE9107-296F-4977-9E85-E2D3D5FD20B1Q50253360-2DA1E44E-4E1A-4A82-BF53-C9222A1396E1Q59000981-BFA7DE1E-6D4A-4868-B0E2-A1D0A727AA40
P2860
Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Vaginal misoprostol administer ...... abortion: A randomized trial.
@en
Vaginal misoprostol administer ...... abortion: A randomized trial.
@nl
type
label
Vaginal misoprostol administer ...... abortion: A randomized trial.
@en
Vaginal misoprostol administer ...... abortion: A randomized trial.
@nl
prefLabel
Vaginal misoprostol administer ...... abortion: A randomized trial.
@en
Vaginal misoprostol administer ...... abortion: A randomized trial.
@nl
P2093
P356
P1476
Vaginal misoprostol administer ...... abortion: A randomized trial.
@en
P2093
C Ellertson
C Westhoff
E A Schaff
L S Stadalius
S H Eisinger
S L Fielding
P304
P356
10.1001/JAMA.284.15.1948
P407
P577
2000-10-01T00:00:00Z